Page last updated: 2024-10-26

dimethadione and Cancer of Kidney

dimethadione has been researched along with Cancer of Kidney in 1 studies

Dimethadione: An anticonvulsant that is the active metabolite of TRIMETHADIONE.

Research Excerpts

ExcerptRelevanceReference
" At dosage levels equimolar to 500 ppm PB, none of the three compounds promoted development of hepatocellular adenomas or carcinomas, in contrast to PB."1.28Effects of the oxazolidinedione anticonvulsants trimethadione and dimethadione and the barbiturate homolog 5,5-dimethylbarbituric acid on N-nitrosodiethylamine-initiated renal and hepatic carcinogenesis in the F344/NCr rat. ( Diwan, BA; Henneman, JR; Lubet, RA; Nims, RW; Rice, JM; Ward, JM, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diwan, BA1
Nims, RW1
Henneman, JR1
Ward, JM1
Lubet, RA1
Rice, JM1

Other Studies

1 other study available for dimethadione and Cancer of Kidney

ArticleYear
Effects of the oxazolidinedione anticonvulsants trimethadione and dimethadione and the barbiturate homolog 5,5-dimethylbarbituric acid on N-nitrosodiethylamine-initiated renal and hepatic carcinogenesis in the F344/NCr rat.
    Archives of toxicology, 1992, Volume: 66, Issue:6

    Topics: Animals; Barbiturates; Body Weight; Cocarcinogenesis; Cytochrome P-450 CYP2B1; Cytochrome P-450 Enzy

1992
chemdatabank.com